Activation of cGAS-STING Signal to Inhibit the Proliferation of Bladder Cancer: The Immune Effect of Cisplatin

Cisplatin is commonly used in neoadjuvant, adjuvant, and systemic therapy for advanced bladder cancer, but its immune-related mechanism is still unclear. Exploration of the immune effects of cisplatin in bladder cancer would complement the comprehensive mechanism of cisplatin and provide the basis f...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Guanghou, Wu, Yunfei, Zhao, Guanan, Chen, Xiaoyi, Xu, Zhijie, Sun, Junjie, Tian, Junjie, Cheng, Zhengjun, Shi, Yue, Jin, Baiye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564335/
https://www.ncbi.nlm.nih.gov/pubmed/36230972
http://dx.doi.org/10.3390/cells11193011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564335/
https://www.ncbi.nlm.nih.gov/pubmed/36230972
http://dx.doi.org/10.3390/cells11193011

Ejemplares similares